YouSigma- the web's most extensive resource for information
$6.99 Domain Names at Network SolutionsĀ®!
Biogen Idec (SWOT Analysis)

Go to Home Page

Tell your friend about this WebSite!

Download PDF Version!

“SWOT is an acronym for the internal Strengths and Weaknesses of a firm and the environmental Opportunities and Threats facing that firm. SWOT analysis is a widely used technique through which managers create a quick overview of a company’s strategic situation. The technique is based on the assumption that an effective strategy derives from a sound “fit” between a firm’s internal resources (strengths and weaknesses) and its external situation (opportunities and threats). A good fit maximizes a firm’s strengths and opportunities and minimizes its weaknesses and threats. Accurately applied, this simple assumption has powerful implications for the design of a successful strategy.”

Biogen Idec

Biogen Idec is a biopharmaceutical company engaged in the process of discovering, developing, manufacturing, and commercializing the therapies in the areas of oncology, neurology and immunology. The company's key products include TYSABRI (natalizumab), AVONEX (Interferon beta-1a), and RITUXAN (rituximab). The company primarily operates in the US and Europe. It is headquartered in Cambridge, Massachusetts and employs about 4,700 people.

Strengths, Weaknesses, Opportunities and Threats (SWOT)

Location of Factor

TYPE OF FACTOR

Favorable

Unfavorable

Internal

Strengths

  • Strong licensing network

Weaknesses

  • Heavy reliance on the marketing efforts of its partner, Genentech
  • Lack of broad sales and marketing experience in the oncology and inflammation markets

External

Opportunities

  • Well populated mAb pipeline to boost oncology offering
  • Possible M&A activity

Threats

  • Restrictions imposed to the prescription of Tysabri leading to cannibalization of the company ’s leading franchise, Avonex
  • Introduction of other small molecule multiple sclerosis drugs impacting the sales of Avonex
underline
About YouSigma Please Donate Using PayPal, to help us Develop Content
Copyright and Disclaimer
Loading
underline
underline
Try a free sample Destiny Reading! Executive Openings! $80,000 to $500,000+
"Biogen Idec (SWOT Analysis)";